Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States
- 30 December 2017
- journal article
- research article
- Published by Springer Nature in AIDS and Behavior
- Vol. 22 (11) , 3540-3549
Abstract
Adherence challenges with oral pre-exposure prophylaxis have stimulated interest in alternate modes of administration including long-acting injections. We conducted 30 in-depth interviews with 26 male trial participants and 4 clinical providers in a Phase IIa study (ÉCLAIR) evaluating the use of long-acting cabotegravir (CAB-LA) injections in New York and San Francisco. Interviews exploring attitudes and experiences with CAB-LA were audiotaped, transcribed, and analyzed using thematic content analysis. Despite a high frequency of some level of side effects, almost all participants reported being interested in continuing with CAB-LA, versus a daily oral, due to its convenience and the perceived advantage of not worrying about adhering to pills. Providers reinforced the importance of CAB-LA as a prevention option and the need for guidelines to assist patient decision-making. Further research is needed on the acceptability of CAB-LA among men and women at higher risk for HIV in different settings.Keywords
Funding Information
- ViiV Healthcare
This publication has 44 references indexed in Scilit:
- PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in the United States, 2009–2015PLOS ONE, 2016
- Preexposure Prophylaxis Modality Preferences Among Men Who Have Sex With Men and Use Social Media in the United StatesJournal of Medical Internet Research, 2016
- An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxisTrials, 2016
- Knowledge, Attitudes, and Likelihood of Pre-Exposure Prophylaxis (PrEP) Use Among US Women at Risk of Acquiring HIVAIDS Patient Care and STDs, 2015
- HIV Providers’ Perceived Barriers and Facilitators to Implementing Pre-exposure Prophylaxis in Care Settings: A Qualitative StudyAIDS and Behavior, 2014
- Are Thai MSM Willing to Take PrEP for HIV Prevention? An Analysis of Attitudes, Preferences and AcceptancePLOS ONE, 2013
- Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in BotswanaNew England Journal of Medicine, 2012
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and WomenNew England Journal of Medicine, 2012
- Willingness to Accept HIV Pre-Exposure Prophylaxis among Chinese Men Who Have Sex with MenPLOS ONE, 2012
- Pre-exposure Prophylaxis State of the Science: Empirical Analogies for Research and ImplementationCurrent HIV/AIDS Reports, 2010